These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 31722736)

  • 41. Clinical Relevance and Immunosuppressive Pattern of Circulating and Infiltrating Subsets of Myeloid-Derived Suppressor Cells (MDSCs) in Epithelial Ovarian Cancer.
    Okła K; Czerwonka A; Wawruszak A; Bobiński M; Bilska M; Tarkowski R; Bednarek W; Wertel I; Kotarski J
    Front Immunol; 2019; 10():691. PubMed ID: 31001284
    [TBL] [Abstract][Full Text] [Related]  

  • 42. S100A9 maintains myeloid-derived suppressor cells in chronic sepsis by inducing miR-21 and miR-181b.
    Alkhateeb T; Kumbhare A; Bah I; Youssef D; Yao ZQ; McCall CE; El Gazzar M
    Mol Immunol; 2019 Aug; 112():72-81. PubMed ID: 31078118
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Myeloid-Derived Suppressor Cells Contribute to Susceptibility to
    Onyilagha C; Kuriakose S; Ikeogu N; Jia P; Uzonna J
    J Immunol; 2018 Jul; 201(2):507-515. PubMed ID: 29898961
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Suppression of T cells by myeloid-derived suppressor cells in cancer.
    Chen J; Ye Y; Liu P; Yu W; Wei F; Li H; Yu J
    Hum Immunol; 2017 Feb; 78(2):113-119. PubMed ID: 27939507
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Roles of Myeloid-Derived Suppressor Cell Subpopulations in Autoimmune Arthritis.
    Li M; Zhu D; Wang T; Xia X; Tian J; Wang S
    Front Immunol; 2018; 9():2849. PubMed ID: 30564242
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Physical activity delays accumulation of immunosuppressive myeloid-derived suppressor cells.
    Garritson J; Krynski L; Haverbeck L; Haughian JM; Pullen NA; Hayward R
    PLoS One; 2020; 15(6):e0234548. PubMed ID: 32542046
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CD33
    Sun Y; Shao J; Jiang F; Wang Y; Yan Q; Yu N; Zhang J; Zhang J; Li M; He Y
    Am J Reprod Immunol; 2019 Jan; 81(1):e13067. PubMed ID: 30375700
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stat3 and C/EBPβ synergize to induce miR-21 and miR-181b expression during sepsis.
    McClure C; McPeak MB; Youssef D; Yao ZQ; McCall CE; El Gazzar M
    Immunol Cell Biol; 2017 Jan; 95(1):42-55. PubMed ID: 27430527
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Myeloid-Derived Suppressor Cells Gain Suppressive Function during Neonatal Bacterial Sepsis.
    Vance JK; Rawson TW; Povroznik JM; Brundage KM; Robinson CM
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34208904
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circulating Myeloid-Derived Suppressor Cell Subsets in Patients with Colorectal Cancer - Exploratory Analysis of Their Biomarker Potential.
    Fědorová L; Pilátová K; Selingerová I; Bencsiková B; Budinská E; Zwinsová B; Brychtová V; Langrová M; Šefr R; Valík D; Zdražilová Dubská L
    Klin Onkol; 2018; 31(Suppl 2):88-92. PubMed ID: 31023030
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The novel α-glucan YCP improves the survival rates and symptoms in septic mice by regulating myeloid-derived suppressor cells.
    Liu D; You M; Zhao GF; Li XJ; Song YX; Dou H; Yao WB; Gao XD; Hou YY
    Acta Pharmacol Sin; 2017 Sep; 38(9):1269-1281. PubMed ID: 28649127
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CD11b+Gr-1+ myeloid-derived suppressor cells reduce atherosclerotic lesion development in LDLr deficient mice.
    Foks AC; Van Puijvelde GH; Wolbert J; Kröner MJ; Frodermann V; Van Der Heijden T; Van Santbrink PJ; Boon L; Bot I; Kuiper J
    Cardiovasc Res; 2016 Aug; 111(3):252-61. PubMed ID: 27234908
    [TBL] [Abstract][Full Text] [Related]  

  • 53. GM-CSF Promotes the Expansion and Differentiation of Cord Blood Myeloid-Derived Suppressor Cells, Which Attenuate Xenogeneic Graft-vs.-Host Disease.
    Park MY; Lim BG; Kim SY; Sohn HJ; Kim S; Kim TG
    Front Immunol; 2019; 10():183. PubMed ID: 30863394
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Continuous renal replacement therapy attenuates polymorphonuclear myeloid-derived suppressor cell expansion in pediatric severe sepsis.
    Feng S; Cui Y; Zhou Y; Shao L; Miao H; Dou J; Liu T; Wang C; Zhang Y
    Front Immunol; 2022; 13():990522. PubMed ID: 36263056
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MDSCs in sepsis-induced immunosuppression and its potential therapeutic targets.
    Zhang W; Fang X; Gao C; Song C; He Y; Zhou T; Yang X; Shang Y; Xu J
    Cytokine Growth Factor Rev; 2023 Feb; 69():90-103. PubMed ID: 35927154
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IFN-α-based treatment of patients with chronic HCV show increased levels of cells with myeloid-derived suppressor cell phenotype and of IDO and NOS.
    Salem ML; Zidan AA; Attia M; El-Naggar RE; Nassef M; Abou El-Azm AR; El-Bate H; Yussif M; Galal S; Abo Senna M; El Demellawy M
    Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):188-198. PubMed ID: 28472907
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phenotypic and functional alterations of myeloid-derived suppressor cells during the disease course of multiple sclerosis.
    Iacobaeus E; Douagi I; Jitschin R; Marcusson-Ståhl M; Andrén AT; Gavin C; Lefsihane K; Davies LC; Mougiakakos D; Kadri N; Le Blanc K
    Immunol Cell Biol; 2018 Sep; 96(8):820-830. PubMed ID: 29569304
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surgery-induced monocytic myeloid-derived suppressor cells expand regulatory T cells in lung cancer.
    Wang J; Yang L; Yu L; Wang YY; Chen R; Qian J; Hong ZP; Su XS
    Oncotarget; 2017 Mar; 8(10):17050-17058. PubMed ID: 28178645
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Myeloid Cell-Specific Knockout of NFI-A Improves Sepsis Survival.
    McPeak MB; Youssef D; Williams DA; Pritchett C; Yao ZQ; McCall CE; El Gazzar M
    Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28167668
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Myeloid-Derived Suppressor Cells in Psoriasis Are an Expanded Population Exhibiting Diverse T-Cell-Suppressor Mechanisms.
    Cao LY; Chung JS; Teshima T; Feigenbaum L; Cruz PD; Jacobe HT; Chong BF; Ariizumi K
    J Invest Dermatol; 2016 Sep; 136(9):1801-1810. PubMed ID: 27236103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.